BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Viayna E, Coquelle N, Cieslikiewicz-Bouet M, Cisternas P, Oliva CA, Sánchez-López E, Ettcheto M, Bartolini M, De Simone A, Ricchini M, Rendina M, Pons M, Firuzi O, Pérez B, Saso L, Andrisano V, Nachon F, Brazzolotto X, García ML, Camins A, Silman I, Jean L, Inestrosa NC, Colletier JP, Renard PY, Muñoz-Torrero D. Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice. J Med Chem 2021;64:812-39. [PMID: 33356266 DOI: 10.1021/acs.jmedchem.0c01775] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li HH, Wu C, Zhang SL, Yang JG, Qin HL, Tang W. Fluorosulfate-containing pyrazole heterocycles as selective BuChE inhibitors: structure-activity relationship and biological evaluation for the treatment of Alzheimer's disease. J Enzyme Inhib Med Chem 2022;37:2099-111. [PMID: 35899776 DOI: 10.1080/14756366.2022.2103553] [Reference Citation Analysis]
2 Liu C, Sang Z, Pan H, Wu Q, Qiu Y, Shi J. A Novel Multifunctional 5,6-Dimethoxy-Indanone-Chalcone-Carbamate Hybrids Alleviates Cognitive Decline in Alzheimer’s Disease by Dual Inhibition of Acetylcholinesterase and Inflammation. Front Aging Neurosci 2022;14:922650. [DOI: 10.3389/fnagi.2022.922650] [Reference Citation Analysis]
3 Jansa P, Barvík I, Hulcová D, Matoušová E. Synthesis and cholinesterase inhibitory activity study of Amaryllidaceae alkaloid analogues with N-methyl substitution. Org Biomol Chem 2022;20:3960-6. [PMID: 35471452 DOI: 10.1039/d2ob00553k] [Reference Citation Analysis]
4 Sampietro A, Pérez-areales FJ, Martínez P, Arce EM, Galdeano C, Muñoz-torrero D. Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis. Pharmaceuticals 2022;15:545. [DOI: 10.3390/ph15050545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yao C, Jiang X, Zhao R, Zhong Z, Ge J, Zhu J, Ye XY, Xie Y, Liu Z, Xie T, Bai R. HDAC1/MAO-B dual inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation of N-propargylamine-hydroxamic acid/o-aminobenzamide hybrids. Bioorg Chem 2022;122:105724. [PMID: 35305483 DOI: 10.1016/j.bioorg.2022.105724] [Reference Citation Analysis]
6 Codony S, Pont C, Griñán-Ferré C, Di Pede-Mattatelli A, Calvó-Tusell C, Feixas F, Osuna S, Jarné-Ferrer J, Naldi M, Bartolini M, Loza MI, Brea J, Pérez B, Bartra C, Sanfeliu C, Juárez-Jiménez J, Morisseau C, Hammock BD, Pallàs M, Vázquez S, Muñoz-Torrero D. Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease. J Med Chem 2022. [PMID: 35271276 DOI: 10.1021/acs.jmedchem.1c02150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
7 Da Silva O, Probst N, Landry C, Hanak AS, Warnault P, Coisne C, Calas AG, Gosselet F, Courageux C, Gastellier AJ, Trancart M, Baati R, Dehouck MP, Jean L, Nachon F, Renard PY, Dias J. A New Class of Bi- and Trifunctional Sugar Oximes as Antidotes against Organophosphorus Poisoning. J Med Chem 2022. [PMID: 35255209 DOI: 10.1021/acs.jmedchem.1c01748] [Reference Citation Analysis]
8 Oliva CA, Rivera DS, Mariqueo TA, Bozinovic F, Inestrosa NC. Differential Role of Sex and Age in the Synaptic Transmission of Degus (Octodon degus). Front Integr Neurosci 2022;16:799147. [DOI: 10.3389/fnint.2022.799147] [Reference Citation Analysis]
9 Singh YP, Kumar N, Priya K, Chauhan BS, Shankar G, Kumar S, Singh GK, Srikrishna S, Garg P, Singh G, Rai G, Modi G. Exploration of Neuroprotective Properties of a Naturally Inspired Multifunctional Molecule (F24) against Oxidative Stress and Amyloid β Induced Neurotoxicity in Alzheimer's Disease Models. ACS Chem Neurosci 2022;13:27-42. [PMID: 34931800 DOI: 10.1021/acschemneuro.1c00443] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Shi Y, Zhang H, Song Q, Yu G, Liu Z, Zhong F, Tan Z, Liu X, Deng Y. Development of novel 2-aminoalkyl-6-(2-hydroxyphenyl)pyridazin-3(2H)-one derivatives as balanced multifunctional agents against Alzheimer's disease. Eur J Med Chem 2022;230:114098. [PMID: 35026532 DOI: 10.1016/j.ejmech.2021.114098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pont C, Ginex T, Griñán-Ferré C, Scheiner M, Mattellone A, Martínez N, Arce EM, Soriano-Fernández Y, Naldi M, De Simone A, Barenys M, Gómez-Catalán J, Pérez B, Sabate R, Andrisano V, Loza MI, Brea J, Bartolini M, Bolognesi ML, Decker M, Pallàs M, Luque FJ, Muñoz-Torrero D. From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects. Eur J Med Chem 2021;225:113779. [PMID: 34418785 DOI: 10.1016/j.ejmech.2021.113779] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Remya C, Dileep KV, Koti Reddy E, Mantosh K, Lakshmi K, Sarah Jacob R, Sajith AM, Jayadevi Variyar E, Anwar S, Zhang KYJ, Sadasivan C, Omkumar RV. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation. Comput Struct Biotechnol J 2021;19:4517-37. [PMID: 34471497 DOI: 10.1016/j.csbj.2021.07.041] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
13 Dolezal R. Accuracy and precision of binding free energy prediction for a tacrine related lead inhibitor of acetylcholinesterase with an arsenal of supercomputerized molecular modelling methods: a comparative study. J Biomol Struct Dyn 2021;:1-29. [PMID: 34323654 DOI: 10.1080/07391102.2021.1957716] [Reference Citation Analysis]
14 Matos MJ. Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion? Future Med Chem 2021;13:1301-9. [PMID: 34137271 DOI: 10.4155/fmc-2021-0119] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Mezeiova E, Hrabinova M, Hepnarova V, Jun D, Janockova J, Muckova L, Prchal L, Kristofikova Z, Kucera T, Gorecki L, Chalupova K, Kunes J, Hroudova J, Soukup O, Korabecny J. Huprine Y - Tryptophan heterodimers with potential implication to Alzheimer's disease treatment. Bioorg Med Chem Lett 2021;43:128100. [PMID: 33984470 DOI: 10.1016/j.bmcl.2021.128100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 de Andrade Ramos G, Souza de Oliveira A, Bartolini M, Naldi M, Liparulo I, Bergamini C, Uliassi E, Wu L, Fraser PE, Abreu M, Kiametis AS, Gargano R, Silveira ER, Brand GD, Prchal L, Soukup O, Korábečný J, Bolognesi ML, Soares Romeiro LA. Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties. RSC Med Chem 2021;12:1154-63. [PMID: 34355181 DOI: 10.1039/d1md00046b] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
17 Rossi M, Freschi M, de Camargo Nascente L, Salerno A, de Melo Viana Teixeira S, Nachon F, Chantegreil F, Soukup O, Prchal L, Malaguti M, Bergamini C, Bartolini M, Angeloni C, Hrelia S, Soares Romeiro LA, Bolognesi ML. Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease. J Med Chem 2021;64:4972-90. [PMID: 33829779 DOI: 10.1021/acs.jmedchem.1c00048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]